Luftner D, Tesch H, Schmidt M, Hartkopf AD, et al. Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET study. Eur J Cancer 2021;150:268-277.
PMID: 33971386